Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer.
about
Prevalence and natural history of ALK positive non-small-cell lung cancer and the clinical impact of targeted therapy with ALK inhibitorsFluorescence in situ hybridization and immunohistochemistry as diagnostic methods for ALK positive non-small cell lung cancer patientsSignificance of targeted therapy and genetic alterations in EGFR, ALK, or KRAS on survival in patients with non-small cell lung cancer treated with radiotherapy for brain metastasesThe Impact of Molecularly Targeted Treatment on Direct Medical Costs in Patients with Advanced Non-small Cell Lung Cancer.Biomarkers and targeted systemic therapies in advanced non-small cell lung cancerLung cancer: Biology and treatment options.Crizotinib for the treatment of ALK-rearranged non-small cell lung cancer: a success story to usher in the second decade of molecular targeted therapy in oncologyPemetrexed-based chemotherapy in patients with advanced, ALK-positive non-small cell lung cancerEML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3The molecular detection and clinical significance of ALK rearrangement in selected advanced non-small cell lung cancer: ALK expression provides insights into ALK targeted therapy.Activity and safety of crizotinib in patients with ALK-positive non-small-cell lung cancer: updated results from a phase 1 study.Treating ALK-positive lung cancer--early successes and future challenges.Current status of targeted therapy for anaplastic lymphoma kinase-rearranged non-small cell lung cancer.Ceritinib for treatment of ALK-rearranged advanced non-small-cell lung cancer.Small-molecule EGFR tyrosine kinase inhibitors for the treatment of cancer.Clinical challenges in targeting anaplastic lymphoma kinase in advanced non-small cell lung cancer.Treatment modalities for advanced ALK-rearranged non-small-cell lung cancer.Worse disease-free, tumor-specific, and overall survival in surgically-resected lung adenocarcinoma patients with ALK rearrangement.ALK protein expression in pulmonary adenocarcinoma of Tunisian patients.[Clinical Advanced in Early-stage ALK-positive Non-small Cell Lung Cancer Patients].
P2860
Q34564071-11006512-7357-48D9-9EF8-9E87118F1BAEQ34566472-B554AFB8-6B9B-43F0-9431-989C0984BA66Q34886787-3AC9E7A0-6A98-4869-8F82-FE1542D86448Q35429767-056B0C09-C93E-4548-9A6A-E781C4236889Q36260477-E4932165-FA02-4A23-BAAF-AA7C2C324BF0Q36328370-42A0E2A8-7C70-4E60-8D19-3D9A8A889CB0Q36405628-11041119-8D62-4166-ADF2-53F896600479Q36474900-B4582DB7-6663-474B-AB4B-46406062CA22Q36821217-717C4015-9149-47EC-BFBB-318CCCE726AEQ37431563-DE97B101-C82C-4226-A79C-9B5C1E3B9A30Q37606591-11B21E9A-4FCB-4A55-91FB-563811A3DF0AQ37999657-8AAA6791-E98C-4E39-9983-A5D255B8A887Q38148969-CA8E545F-E3E6-4678-9243-BCC0C65A6DF2Q38214154-2A4C355A-EC28-48F7-B6F3-C914B4776DB1Q38219688-7C6BD425-BB7B-4614-A1B8-AEC7032EEE19Q38241120-9423B433-42E2-4B9C-91AA-29973C962ECDQ38739807-5E7BB334-611A-4F0C-A31F-EAC1296D3728Q47097774-E7FCB935-3BC8-443C-9FCD-F1D1980FD23FQ51049573-54D940FA-D016-4757-9584-54CEF480E285Q52902964-4177ABC0-57D9-430F-875A-6D5E842FF0EC
P2860
Comparative analyses of overall survival in patients with anaplastic lymphoma kinase-positive and matched wild-type advanced nonsmall cell lung cancer.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Comparative analyses of overal ...... ced nonsmall cell lung cancer.
@en
Comparative analyses of overal ...... ced nonsmall cell lung cancer.
@nl
type
label
Comparative analyses of overal ...... ced nonsmall cell lung cancer.
@en
Comparative analyses of overal ...... ced nonsmall cell lung cancer.
@nl
prefLabel
Comparative analyses of overal ...... ced nonsmall cell lung cancer.
@en
Comparative analyses of overal ...... ced nonsmall cell lung cancer.
@nl
P2093
P2860
P356
P1433
P1476
Comparative analyses of overal ...... ced nonsmall cell lung cancer.
@en
P2093
Dae Seog Heo
Dong-Wan Kim
Doo Hyun Chung
Heae Surng Park
June Koo Lee
Kimary Kulig
Se-Hoon Lee
Tae Min Kim
Woo-Ho Kim
Yoon-Kyung Jeon
P2860
P304
P356
10.1002/CNCR.26668
P407
P577
2011-11-15T00:00:00Z